A conservative advocacy group says nearly 330,000 abortion pills were shipped into states with abortion restrictions under the protection of blue-state shield laws, raising new questions about the post-Roe legal fight over abortion access.
The Restoration of America Foundation released a report marking the anniversary of the Supreme Court’s 2022 decision overturning Roe v. Wade. The group said abortion medication has continued flowing into states with strict abortion laws because providers in states with abortion protections are shielded from legal action by states with bans or limits.
According to the report, which cites data from the Society of Family Planning’s #WeCount project, more than 328,000 abortion pills were sent from out-of-state providers into states with abortion restrictions between July 2023 and December 2025. The group said monthly shipments nearly tripled during that period, rising from about 5,400 in July 2023 to nearly 14,900 in December 2025.
The report argues that out-of-state abortion providers are now sending close to 15,000 medication abortion shipments per month into states with restrictions.
TRENDING TODAY
The issue has become one of the most contested parts of abortion policy after Dobbs, the Supreme Court ruling that returned abortion lawmaking power to individual states. While many Republican-led states passed bans or strict limits, several Democratic-led states adopted shield laws designed to protect abortion providers who treat patients across state lines, including through telehealth.
Supporters of shield laws say they help preserve access to abortion care for patients in states where clinics have closed or abortion is heavily restricted. They argue that states protecting abortion rights should not help enforce another state’s abortion ban.
Opponents say the laws undermine the ability of conservative states to enforce their own abortion restrictions. The Restoration of America Foundation argues that mail-order abortion has weakened state-level bans and allowed abortion numbers in some restrictive states to remain at or above pre-Dobbs levels.
The report says nine states with abortion restrictions — including Alabama, Arkansas, Florida, Kentucky, Louisiana, Mississippi, South Carolina, South Dakota and Texas — recorded more monthly abortions in 2025 than they did in 2022 before Roe was overturned.
Republican officials in states such as Texas and Louisiana have attempted to pursue legal action against out-of-state providers, but those efforts have faced major obstacles when Democratic governors in states such as California and New York refused to cooperate with extradition or enforcement actions.
The report calls on the Trump administration to reverse Biden-era Food and Drug Administration policy changes that expanded access to medication abortion through telehealth and mail delivery. It also urges the Justice Department to revisit federal laws governing the mailing of abortion drugs, including the Comstock Act.
Medication abortion, commonly involving mifepristone and misoprostol, has become the dominant method of abortion in the United States. The FDA has said mifepristone is safe and effective when used under approved conditions, while abortion opponents argue that mail distribution raises safety and legal concerns.
The report also says 22 states and Washington, D.C., have adopted some form of abortion shield law, including several that explicitly protect providers prescribing abortion medication by telehealth to patients in states with restrictions.
The debate now puts the Trump administration in a politically difficult position. Trump has said abortion policy should largely be left to the states, while anti-abortion groups are urging federal action to stop abortion pills from being mailed into states with bans.
Why It Matters
The report highlights a central conflict in post-Roe America: whether abortion restrictions can be enforced when medication can be prescribed remotely and mailed across state lines. For abortion opponents, shield laws weaken state bans. For abortion-rights supporters, they protect access for patients who live under restrictive laws.
What Comes Next
The Trump administration may face growing pressure from anti-abortion groups to reverse FDA policies on medication abortion and reconsider federal enforcement involving mailed abortion drugs. At the same time, blue states are likely to defend shield laws, setting up continued legal clashes between states with opposing abortion policies.
